业界动态监管公开信息 · FDA

关于模型引导的药物开发通用原则新最终指南(ICH M15)的利益相关方参与网络研讨会 - 2026年10月29日

FDA Drugs · 2026-11-13 01:05

正文 · 中文译文

网络直播 | 线上 活动标题 关于模型引导药物开发通用原则新最终指南(ICH M15)利益相关方参与网络研讨会 2026年10月29日 更多会议、大会和研讨会 人用药品新闻与活动 会议、大会和研讨会 重要批准 CDER对话 我们的视角 CDER科学聚焦 关于……需要了解的事项 日期: 2026年10月29日 时间: 上午8:30 - 上午10:00 美国东部时间 观看录制的网络研讨会 预录报告 关于本次活动 新的ICH M15指南《模型引导药物开发的通用原则》于2026年2月由国际人用药品注册技术协调会(ICH)通过,为模型引导药物开发(MIDD)所得证据的规划、模型评价和文档记录提供了一般性建议。本指南建立了MIDD证据的统一评估框架(包括相关术语)。 2026年6月,FDA通过发布题为《M15模型引导药物开发通用原则》的最终行业指南,实施了ICH M15指南。 本次网络研讨会介绍最终的M15指南,解释指南中引入的概念,通过案例示例进行说明,并解答关于应用这些原则的常见问题。 本次活动包括两个独立的场次: 预录报告,说明ICH M15指南引入的概念和原则 于2026年10月29日举行的网络研讨会,旨在与MIDD领域的科学家进行更广泛的交流 研讨会目标 描述M15最终指南中引入的概念,并促进及时采纳,以简化新药开发和监管互动 解答关于应用该指南引入的一般原则的常见问题 获取反馈,以帮助开发额外的培训材料和案例 会议信息 参会免费,无需注册。如需了解有关此活动的更多信息或提交问题,请联系 DPM-CONTACT@fda.hhs.gov。 内容截至日期: 11/12/2026 受监管产品 药品

正文 · 英文原文

Webcast | Virtual Event Title Webinar for Stakeholder Engagement on the New Final Guideline on General Principles for Model-Informed Drug Development (ICH M15) October 29, 2026 More Meetings, Conferences, and Workshops News & Events for Human Drugs Meetings, Conferences, & Workshops Notable Approvals CDER Conversations From Our Perspective Spotlight on CDER Science Things to Know About... Date: October 29, 2026 Time: 8:30 a.m. - 10:00 a.m. ET View the Recorded Webinar Pre-recorded Presentations About This Event Adopted by the International Council for Harmonisation (ICH) in February 2026, the new ICH M15 guideline, “General Principles for Model-Informed Drug Development,” provides general recommendations for planning, model evaluation, and documentation of evidence derived from model-informed drug development (MIDD). This guideline establishes a harmonized assessment framework (including associated terminology) for MIDD evidence. In June 2026, FDA implemented the ICH M15 guideline by issuing the final guidance for industry titled “M15 General Principles for Model-Informed Drug Development.” This webinar presents the final M15 guideline, explaining the concepts introduced in the guideline, illustrating them through a case example, and addressing common questions about applying these principles. This event includes two separate sessions: Pre-recorded presentations illustrating concepts and principles introduced by the ICH M15 guideline A webinar that occurred on October 29, 2026, for broader engagement with scientists in the MIDD community Workshop Objectives Describe the concepts introduced in the M15 final guideline and facilitate timely adoption to streamline new drug development and regulatory interaction Address common questions on applying the general principles introduced by the guideline Obtain feedback to aid the development of additional training materials and case examples Meeting Information There is no cost to attend, and registration is not required. For more information about this event or to submit questions, please contact DPM-CONTACT@fda.hhs.gov. Content current as of: 11/12/2026 Regulated Product(s) Drugs

English
Webinar for Stakeholder Engagement on the New Final Guideline on General Principles for Model-Informed Drug Development (ICH M15) - 10/29/2026
内容仅供参考,不构成诊疗建议,不能替代执业医师的诊断。

← 返回元界